Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.0K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

891
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
891

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Flip Sides of Interventional Glaucoma.

Ophthalmology. Glaucoma·2026
Same author

Long-term follow up (≥ 10 years) of penetrating keratoplasty versus deep anterior lamellar keratoplasty for keratoconus.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Factors associated with graft astigmatism after corneal transplantation for keratoconus.

BMC ophthalmology·2026
Same author

Accuracy and Readability of Chat Generative Pre-Trained Transformer-4 Omni in Answering Ophthalmology Patient Questions.

Ophthalmology science·2026
Same author

Applicability of ChatGPT to generate multiple-choice questions for ophthalmology resident exam.

The British journal of ophthalmology·2025
Same author

Incidence and Risk Factors for Intraoperative Complications in Resident-performed Phacoemulsification Surgery.

Journal of ophthalmic & vision research·2025

Related Experiment Video

Updated: Dec 25, 2025

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
04:00

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

3.0K

Reversible Corneal Endothelial Abnormalities With Netarsudil.

Angelo P Tanna1, Hamed Esfandiari, Kyla Teramoto

  • 1Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL.

Journal of Glaucoma
|April 1, 2020
PubMed
Summary

Topical netarsudil treatment can cause reversible corneal endothelial abnormalities, presenting as blurred vision and guttata-like changes. These effects resolved after discontinuing netarsudil, highlighting a potential side effect for ophthalmologists to monitor.

More Related Videos

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
04:48

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

673
Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models
06:10

Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models

Published on: December 8, 2023

2.2K

Related Experiment Videos

Last Updated: Dec 25, 2025

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
04:00

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

3.0K
Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
04:48

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

673
Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models
06:10

Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models

Published on: December 8, 2023

2.2K

Area of Science:

  • Ophthalmology
  • Corneal Science
  • Pharmacology

Background:

  • A case study investigating corneal endothelial changes associated with topical glaucoma medication.
  • Focus on the fixed-dose combination of netarsudil and latanoprost in managing primary open-angle glaucoma.

Observation:

  • A 68-year-old woman experienced blurred vision after initiating fixed-dose combination netarsudil-latanoprost.
  • Slit-lamp examination revealed guttata-like corneal endothelial abnormalities in both eyes.
  • Specular microscopy showed irregular corneal endothelial cells with indistinct borders.

Findings:

  • Discontinuation of netarsudil in one eye led to resolution of corneal endothelial abnormalities and improved visual acuity.
  • Continued netarsudil treatment in the other eye showed no change in endothelial abnormalities.
  • Corneal endothelial changes associated with netarsudil appear to be transient and reversible.

Implications:

  • Topical netarsudil may induce reversible corneal endothelial cell abnormalities.
  • Specular microscopy is a valuable tool for detecting these drug-induced changes.
  • Ophthalmologists should consider netarsudil-induced corneal toxicity in patients presenting with blurred vision.